Through the Arkansas Opioid Recovery Partnership, we have funded innovative programs aimed to slow the relentless increase in ...
The Drug Enforcement Administration (DEA), in concert with other federal agencies, has taken various steps in the past few ...
FDA feedback confirms Adial's proposed in vitro bridging strategy to the Phase 3 formulation to fulfill the bridging ...
Health care providers can now administer Sublocade subcutaneously into the thigh, buttock, or the back of the upper arm, in addition to the abdomen.
Indian authorities banned the manufacturing and export of Tapentadol, Carisoprodol combination drugs, two highly addictive ...
The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...
Palghar: The Union health ministry has stopped operations and production of Aveo Pharmaceuticals Ltd. (Aveo) following ...
Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...
In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...
Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback